Literature DB >> 27628258

High prostatic fascia release or standard nerve sparing? A viewpoint from Columbia University Medical Center.

Ketan K Badani1.   

Abstract

The technique of lateral prostatic fascia nerve sparing has shown improved recovery of sexual function results after robotic prostatectomy. Using strict criteria to identify men with low-risk prostate cancer, this form of nerve preservation can be safely performed without compromising cancer control.

Entities:  

Keywords:  Nerve-sparing prostatectomy; Potency; Prostate cancer; Robotic prostatectomy

Year:  2008        PMID： 27628258     DOI： 10.1007/s11701-008-0103-9

Source DB:  PubMed          Journal:  J Robot Surg        ISSN： 1863-2483


  4 in total

1.  Robotic radical prostatectomy with the "Veil of Aphrodite" technique: histologic evidence of enhanced nerve sparing.

Authors:  Adnan T Savera; Sanjeev Kaul; Ketan Badani; Azadeh T Stark; Nikhil L Shah; Mani Menon
Journal:  Eur Urol       Date:  2006-03-09       Impact factor: 20.096

Review 2.  Robotic-assisted laparoscopic radical prostatectomy: a report of the current state.

Authors:  Vipul R Patel; Ketul Shah; Kenneth J Palmer; Rahul Thaly; Geoff Coughlin
Journal:  Expert Rev Anticancer Ther       Date:  2007-09       Impact factor: 4.512

3.  Evolution of robotic radical prostatectomy: assessment after 2766 procedures.

Authors:  Ketan K Badani; Sanjeev Kaul; Mani Menon
Journal:  Cancer       Date:  2007-11-01       Impact factor: 6.860

4.  Functional outcomes and oncological efficacy of Vattikuti Institute prostatectomy with Veil of Aphrodite nerve-sparing: an analysis of 154 consecutive patients.

Authors:  Sanjeev Kaul; Adnan Savera; Ketan Badani; Michael Fumo; Akshay Bhandari; Mani Menon
Journal:  BJU Int       Date:  2006-03       Impact factor: 5.588
  4 in total
  1 in total

Review 1.  Different Nerve-Sparing Techniques during Radical Prostatectomy and Their Impact on Functional Outcomes.

Authors:  Iason Kyriazis; Theodoros Spinos; Arman Tsaturyan; Panagiotis Kallidonis; Jens Uwe Stolzenburg; Evangelos Liatsikos
Journal:  Cancers (Basel)       Date:  2022-03-22       Impact factor: 6.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.